Pharma: Other News To Note
Tuesday, July 9, 2013
GW Pharmaceuticals plc, of Porton Down, UK, said its cannabinoid product Sativex, for use in the treatment of moderate to severe spasticity in multiple sclerosis, is now available in Italy through its partner Almirall S.A., of Barcelona, Spain.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.